TRVN Trevena Inc Company Cash on Hand

Symbol and logo of brand Trevena Inc. (TRVN)

The development of neuropreparations is constrained by strict FDA oversight and patent law. This cash balance chart illustrates current capital dynamics, where the 0.00 level reflects the state of the liquidity parameter. To survive, Trevena, Inc. (TRVN) is minimizing costs through the outsourcing of production and clinical trials, while seeking to license its developments to foreign partners to preserve its business structure.

Company Cash Balance: Trevena Inc (TRVN) for 07/04/2022 - 10/19/2024

Trevena Inc. (TRVN) - metric breakdowns and financial figures

- current price and projected stock value:
Summary company analytics:Trevena Inc.
Signature product of Trevena

Trevena, Inc. develops safe alternatives to opioid analgesics, enabling the company to implement premium pricing. By analyzing the cash balance, an investor assesses the volume of immediately available liquid reserves. This metric measures the daily cash balance required for operations and R&D. The trend of this indicator reveals either the formation of financial momentum or the risk of inefficient capital allocation, which determines the fundamental stability of the asset.

Competitors of Trevena, Inc. (TRVN)

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|PTIX (Protagenic Therapeutics, Inc.) - Company Cash Volume|KTTA: Company Cash Balance|Company Cash Funds Cortigent Medical (CRGT)|ATXI - Company Cash Reserve|Company Cash Volume BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Cash Reserve|CHRO: Company Cash on Hand|Eliem Therapeutics Inc. (ELYM) - Company Cash on Hand|Intra-Cellular Therapies Inc. (ITCI) - Company Cash Funds|Company Total Cash Volume LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Company Cash Volume|Company Cash and Cash Equivalents NKGN (NKGen Biotech Inc)|Company Cash Volume NRBO|Company Cash on Hand Sage Therapeutics Inc SAGE|Company Cash Funds Synaptogenix SNPX|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE